文献速递神经介入DSA

急性缺血性卒中再灌注治疗后早期静脉充盈的系统综述与Meta分析

Early venous filling following reperfusion therapy in acute ischemic stroke: a systematic review and meta-analysis.
PubMed 文献 · Neuroradiology · 2025-08-01

该系统综述与Meta分析纳入12项研究共2446例急性缺血性卒中患者,评估再灌注治疗后数字减影血管造影所见的早期静脉充盈与不良结局的关联。结果显示早期静脉充盈与出血转化、脑实质血肿、症状性颅内出血、影像学脑梗死、恶性脑水肿及90天不良功能结局的风险升高相关。作者认为早期静脉充盈可能作为再灌注治疗后出血事件、影像学脑梗死、恶性脑水肿及不良功能结局的预测指标。

要点

  • 再灌注治疗后DSA出现早期静脉充盈与出血转化风险升高相关(OR=4.31)。
  • 早期静脉充盈与症状性颅内出血风险升高相关(OR=6.43),与影像学脑梗死风险升高相关(OR=15.95)。
  • 早期静脉充盈与90天不良功能结局(mRS≥3)风险升高相关(OR=2.58)。

核心结论

  • 早期静脉充盈可能作为脑再灌注治疗后出血事件、影像学脑梗死、恶性脑水肿及不良功能结局风险升高的预测指标。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、Embase、Cochrane Library和Web of Science数据库,纳入评估急性缺血性卒中再灌注治疗后早期静脉充盈结局的研究。
  • 共纳入12项研究、2446例患者,采用随机效应模型合并数据。
  • 结局包括出血转化、脑实质血肿、出血性梗死、症状性颅内出血、影像学低密度脑梗死、恶性脑水肿及90天后改良Rankin量表评分≥3的不良功能结局。

关键影像表现/征象

  • 早期静脉充盈由数字减影血管造影在血管内治疗后检出,可能提示高灌注和血管损伤。

诊断标准与关键数值

  • 早期静脉充盈与出血转化风险升高相关(OR=4.31,95%CI 3.00–6.21,p<0.001)。
  • 早期静脉充盈与脑实质血肿风险升高相关(OR=5.73,95%CI 2.82–11.65,p<0.001)。
  • 早期静脉充盈与症状性颅内出血风险升高相关(OR=6.43,95%CI 3.49–8.47,p<0.001)。
  • 早期静脉充盈与影像学低密度脑梗死风险升高相关(OR=15.95,95%CI 6.37–39.92,p<0.001)。
  • 早期静脉充盈与恶性脑水肿风险升高相关(OR=3.69,95%CI 2.26–6.04,p<0.001),与90天不良功能结局风险升高相关(OR=2.58,95%CI 1.27–5.23,p=0.009)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Early venous filling (EVF), detected by digital subtraction angiography after endovascular therapy, may indicate hyperperfusion and vascular injury. Emerging evidence suggests that EVF is associated with adverse outcomes and complications, highlighting its potential role as a prognostic imaging marker in acute ischemic stroke (AIS).

METHODS: A systematic search was conducted in the MEDLINE, Embase, Cochrane Library, and Web of Science databases to identify studies evaluating the outcomes of EVF following reperfusion therapy in cases of AIS. The outcomes included hemorrhagic transformation (HT), parenchymal hematoma (PH), hemorrhagic infarction (HI), symptomatic intracranial hemorrhage (sICH), cerebral infarction as hypodensity on imaging, malignant brain edema (MBE), and unfavorable outcome measured by modified Rankin scale (mRS ≥ 3) after 90 days. A meta-analysis using a random-effects model was conducted to pool the data.

RESULTS: In the data analyses of 12 studies and 2,446 patients, the presence of EVF post-reperfusion was associated with increased risks of HT (odds ratio [OR] = 4.31; 95% confidence interval [CI] [3.00, 6.21]; p < 0.001), PH (OR = 5.73; 95% CI [2.82, 11.65]; p < 0.001), sICH (OR = 6.43; 95% CI [3.49, 8.47]; p < 0.001), cerebral infarction (OR = 15.95; 95% CI [6.37, 39.92]; p < 0.001), MBE (OR = 3.69; 95% CI [2.26, 6.04]; p < 0.001), and unfavorable functional outcomes (OR = 2.58; 95% CI [1.27, 5.23]; p = 0.009).

CONCLUSIONS: EVF may serve as a predictor of increased risk of hemorrhagic events, cerebral infarction on imaging, MBE, and unfavorable functional outcomes after brain reperfusion therapy.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Lima NL, Mezzari MHDS, Costa Júnior LCI, et al. Early venous filling following reperfusion therapy in acute ischemic stroke: a systematic review and meta-analysis. Neuroradiology. 2025. PMID: 40748454. doi:10.1007/s00234-025-03722-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。